✦ LIBER ✦

Prevention of 5 fluorouracil associated cardiotoxicity

✍ Scribed by DAVIDSON, J. A.

Book ID: 119844328
Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 106 KB
Volume: 24
Category: Article
ISSN: 0004-8291
DOI: 10.1111/j.1445-5994.1994.tb02187.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Symptomatic Cardiotoxicity Associated wi

Symptomatic Cardiotoxicity Associated with 5-Fluorouracil

✍ Dr. Christine C. Meyer; Dr. Karim Anton Calis; Ms. Laurie B. Burke; Ms. Cynthia 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 742 KB

CARDIOTOXICITY OF 5-FLUOROURACIL

✍ LANGSTEVENSON, D 📂 Article 📅 1977 🏛 The Lancet 🌐 English ⚖ 293 KB

Prophylactic options in patients with 5-

Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity

✍ Cianci, G; Morelli, M F; Cannita, K; Morese, R; Ricevuto, E; Di Rocco, Z C; Porz 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 72 KB

Risk factors and prevention of cardiotox

Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine

✍ Søren Astrup Jensen; Jens Benn Sørensen 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 222 KB

The usefulness of antiplatelet agents in

The usefulness of antiplatelet agents in the prevention of fluorouracil (5-FU) cardiotoxicity

✍ A. Andriani; M. Bibas; A. Beni; G. Gregori; A. Scoppola; G. Zampa 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 93 KB

The clinical syndrome of 5-fluorouracil

The clinical syndrome of 5-fluorouracil cardiotoxicity

✍ John F. Ensley; Bharat Patel; Robert Kloner; Julie A. Kish; Joshua Wynne; Muhyi 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 750 KB

5-fluorouracil (FUra) is one of the most frequently used drugs in cancer treatment, particularly in combination with other agents. Its activity when administered as an infusion rather than a bolus has led to a renewed and increased use. A cardiotoxicity that mimics ischemia has been associated with